Exenatide + Placebo
ApprovedCompleted 0 watching 0 views this week🔥 Hot
85
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 2✓
Phase 35
ApprovedIndication / Disease
Weight Gain
Conditions
Weight Gain
Trial Timeline
Dec 1, 2008 → Jul 1, 2015
NCT ID
NCT00845507About Exenatide + Placebo
Exenatide + Placebo is a approved stage product being developed by Eli Lilly for Weight Gain. The current trial status is completed. This product is registered under clinical trial identifier NCT00845507. Target conditions include Weight Gain.
Hype Score Breakdown
Clinical
30
Activity
20
Company
10
Novelty
10
Community
12
Clinical Trials (12)
| NCT ID | Phase | Status |
|---|---|---|
| NCT01140893 | Phase 2/3 | UNKNOWN |
| NCT01364584 | Pre-clinical | Completed |
| NCT00845507 | Approved | Completed |
| NCT00603239 | Phase 3 | Completed |
| NCT00516074 | Phase 3 | Completed |
| NCT00500370 | Phase 2 | Completed |
| NCT00456885 | Approved | Completed |
| NCT00667732 | Approved | Completed |
| NCT00375492 | Phase 3 | Completed |
| NCT00324363 | Phase 3 | Completed |
| NCT00241423 | Phase 2 | Completed |
| NCT00099320 | Phase 3 | Completed |
Competing Products
20 competing products in Weight Gain